Literature DB >> 23594062

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.

Fabio G Liberante, Andrea Pellagatti, Viktoriya Boncheva, David T Bowen, Ken I Mills, Jacqueline Boultwood, Barbara-Ann Guinn.   

Abstract

Entities:  

Keywords:  PReferentially expressed Antigen of the Melanoma Gene; leukaemia antigens; myelodysplastic syndrome; survival; tumour antigens

Mesh：

Substances：

Year:  2013        PMID： 23594062     DOI： 10.1111/bjh.12352

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Methylation pattern of preferentially expressed antigen of melanoma in acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Ya-Zhen Qin; Yan-Huan Zhang; Xiao-Ying Qin; Hong-Hu Zhu
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

Review 2.  The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer.

Authors:  Yichi Xu; Ruanmin Zou; Jing Wang; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Cell Prolif       Date:  2020-02-05       Impact factor: 6.831

Review 3.  Increasing Role of Targeted Immunotherapies in the Treatment of AML.

Authors:  Jochen Greiner; Marlies Götz; Verena Wais
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.